1 minute reading time (69 words)

Gabapentinoid Use in the United States 2002 through 2015 (Research Letter)

Source: JAMA Internal Medicine
Gabapentin and pregabalin are the 2 clinically used medications in the gabapentinoid drug class. Pregabalin and gabapentin have both been approved by the US Food and Drug Administration for treatment of partial seizures and postherpetic neuralgia. Gabapentin enacarbil has also been approved for restless legs syndrome, while pregabalin has additional approvals for diabetic peripheral neuropathy, neuropathic pain associated with spinal cord injury, and fibromyalgia.
Read more... 

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More